Literature DB >> 20597001

Clostridium difficile isolation and culture techniques.

Mike Wren1.   

Abstract

Clostridium difficile infection (CDI) occurs as a disease with a spectrum of severity ranging from mild, self-limiting diarrhoea to a severe colitis, pseudomembraneous colitis or toxic megacolon. The disease arises as a major complication of antibiotic therapy and is most commonly acquired in hospital. The laboratory investigation of faecal samples is supportive of a clinical suspicion that a patient has the disease. Currently the mainstay of diagnosis is the demonstration of C. difficile toxins in a diarrhoeal sample; only a few laboratories set up cultures for the organism. However, toxin tests should not be used as stand alone tests since some patients with disease do not have detectable levels of toxin in their faeces. Furthermore, other patients may have large amounts of toxin in the faeces and yet remain well. A combination of tests, therefore, should be used to help the physician to establish a diagnosis of CDI. This combination of tests should include culture (with toxin testing of the isolate), demonstration of toxin direct from the faeces and the detection of C. difficile antigen. This chapter outlines the methods used to establish the laboratory diagnosis of CDI and also includes the investigation of environmental samples when it is required to monitor them for the presence of C. difficile.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20597001     DOI: 10.1007/978-1-60327-365-7_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections.

Authors:  Shuyi Chen; Huawei Gu; Chunli Sun; Haiying Wang; Jufang Wang
Journal:  Infection       Date:  2016-09-06       Impact factor: 3.553

Review 2.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Development of TaqMan-based quantitative PCR for sensitive and selective detection of toxigenic Clostridium difficile in human stools.

Authors:  Hiroyuki Kubota; Takafumi Sakai; Agata Gawad; Hiroshi Makino; Takuya Akiyama; Eiji Ishikawa; Kenji Oishi
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

4.  High levels of toxigenic Clostridioides difficile contamination of hospital environments: a hidden threat in hospital-acquired infections in Kenya.

Authors:  Erick Odoyo; Cecilia Kyanya; Winnie Mutai; Lillian Musila
Journal:  Access Microbiol       Date:  2020-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.